Filing Flows › Evofem Biosciences (EVFM) › How it makes money
How Evofem Biosciences (EVFM) makes money
Evofem Biosciences (EVFM) made $2.6M of revenue in the second quarter 2026 (Q2 2026), -45% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $2.6M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $2.6M | -45% |
| Q1 2026 | $899K | +6% |
| Q4 2025 | $9.6M | +35% |
| Q3 2025 | $5.0M | +10% |
| Q2 2025 | $4.8M | +16% |
| Q1 2025 | $845K | -76% |
| Q4 2024 | $7.1M | +47% |
From Evofem Biosciences' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Evofem Biosciences make money?
Evofem Biosciences (EVFM) made $2.6M of revenue in the second quarter 2026 (Q2 2026), -45% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.